Free Trial
→ Iran War Shock: What I Was Told In That Private Meeting (From Banyan Hill Publishing) (Ad)tc pixel
OTCMKTS:GNGBY

Getinge Q4 2025 Earnings Report

Getinge logo
$25.10 +0.20 (+0.80%)
As of 10/6/2026 11:42 AM Eastern
ProfileEarnings HistoryForecast

Getinge EPS Results

Actual EPS
$0.47
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Getinge Revenue Results

Actual Revenue
$1.08 billion
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Getinge Announcement Details

Quarter
Q4 2025
Date
1/27/2026
Time
Before Market Opens
Conference Call Date
N/A
Conference Call Time
N/A

Upcoming Earnings

Getinge's next earnings date is estimated for Tuesday, October 20, 2026, based on past reporting schedules.

Conference Call Resources

Getinge Earnings Headlines

Getinge Schedules Q3 2026 Report Release and Investor Call
 |  tipranks.comhttps://www.tipranks.com/news/company-announcements/getinge-schedules-q3-2026-report-release-and-investor-call?utm_source=marketbeat.com&utm_medium=referral
Getinge AB (publ) (GNGBY) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
September 15, 2026  |  seekingalpha.comhttps://seekingalpha.com/article/4946426-getinge-ab-publ-gngby-presents-at-morgan-stanley-24th-annual-global-healthcare-conference
Do NOT Buy SpaceX – Do This Instead
SpaceX just went public - and Whitney Tilson, Harvard MBA and 30-year Wall Street veteran, says buying in could be a costly mistake. He calls it among the most overhyped, overvalued large-cap offerings ever pushed onto everyday investors. Tilson believes a rare economic event is approaching - one with serious consequences for your portfolio this summer. He has prepared a free analysis outlining what he sees and the specific steps he recommends taking now.tc pixel
October 7 at 1:00 AM  |  Stansberry Research (Ad)
Getinge Industrier AB (GNGBY) Ratios
September 12, 2026  |  uk.investing.comhttps://uk.investing.com/equities/getinge-industrier-ab-ratios
Getinge AB Earnings Call Signals Margin Momentum
July 17, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/getinge-ab-earnings-call-signals-margin-momentum?utm_source=marketbeat.com&utm_medium=referral
Getinge AB (publ) (GNGBY) Q2 2026 Earnings Call Transcript
July 17, 2026  |  seekingalpha.comhttps://seekingalpha.com/article/4923108-getinge-ab-publ-gngby-q2-2026-earnings-call-transcript
See More Getinge Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Getinge? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Getinge and other key companies, straight to your email.

About Getinge

Getinge (OTCMKTS:GNGBY) AB is a Swedish medical technology company that develops products and solutions for hospitals, healthcare providers and life sciences organizations. Its offerings are designed to support surgical procedures, intensive care, infection prevention and the manufacture of pharmaceuticals and other medical products.

The company’s portfolio includes operating room and surgical workflow systems, anesthesia and ventilation equipment, intensive care solutions, cardiovascular devices, sterilization and disinfection systems, and equipment for laboratories and pharmaceutical production. Getinge markets products under brands including Maquet, Atrium, Lancer and Applikon.

Founded in 1904 in Getinge, Sweden, the company serves customers in markets across Europe, North America, Asia and other international regions. Getinge is headquartered in Gothenburg, Sweden, and has been led by President and Chief Executive Officer Mattias Perjos since 2017.

View Getinge Profile
Earnings Tools